CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as CC-8490, work in different ways to stop tumor
cells from dividing so they stop growing or die.
PURPOSE: Phase I trial to study the effectiveness of CC-8490 in treating patients who have
recurrent or refractory high-grade gliomas.